Markianos M, Tripodianakis J, Garelis E
Biol Psychiatry. 1983 Mar;18(3):347-54.
The noradrenergic correlates 3-methoxy-4-hydroxy-phenylglycol (MHPG) in urine and dopamine-beta-hydroxylase (DBH) in plasma were estimated on 3 consecutive days in chronic schizophrenic patients under neuroleptic treatment, 20 without and 22 with tardive dyskinetic symptomatology. Compared to normals, no differences in DBH activities were found, but MHPG excretion was higher in both patient groups. Dichotomy of DBH and MHPG values according to their medians for the 42 patients revealed a higher incidence of low DBH activities and low MHPG excretion in the tardive dyskinesia group, while there were no differences in relation to low or high actual neuroleptic dose.
在接受抗精神病药物治疗的慢性精神分裂症患者中,连续3天对尿液中的去甲肾上腺素能相关物质3-甲氧基-4-羟基苯乙二醇(MHPG)和血浆中的多巴胺β-羟化酶(DBH)进行了评估。其中20例无迟发性运动障碍症状,22例有迟发性运动障碍症状。与正常人相比,未发现DBH活性有差异,但两组患者的MHPG排泄量均较高。根据42例患者DBH和MHPG值的中位数进行二分法分析,发现迟发性运动障碍组中DBH活性低和MHPG排泄低的发生率较高,而与实际抗精神病药物剂量的高低无关。